“RECENT UPDATE ON PYRIMIDINE DERIVATIVES AS POTENTIAL DPP-IV INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS” (2022) Journal of Pharmaceutical Negative Results, pp. 5734–5743. Available at: https://www.pnrjournal.com/index.php/home/article/view/5581 (Accessed: 11 June 2026).